244 related articles for article (PubMed ID: 38149950)
21. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
22. Coexistent cutaneous T-cell lymphoma and B-cell malignancy. French Study Group on Cutaneous Lymphomas.
Grange F; Avril MF; Esteve E; Joly P; Bosq J; de Murets A; Thomine E; Ortoli JC; Duvillard P; Vaillant L
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):724-31. PubMed ID: 7929916
[TBL] [Abstract][Full Text] [Related]
23. Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas.
Dommann SN; Dommann-Scherrer CC; Dours-Zimmermann MT; Zimmermann DR; Kural-Serbes B; Burg G
Arch Dermatol Res; 1996 Apr; 288(4):163-7. PubMed ID: 8967786
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.
Berger CL; Tigelaar R; Cohen J; Mariwalla K; Trinh J; Wang N; Edelson RL
Blood; 2005 Feb; 105(4):1640-7. PubMed ID: 15514008
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of T-cell clonality in archival skin biopsy samples of cutaneous T-cell lymphomas using the biomed-2 PCR protocol.
Lukowsky A; Muche JM; Möbs M; Assaf C; Humme D; Hummel M; Sterry W; Steinhoff M
Diagn Mol Pathol; 2010 Jun; 19(2):70-7. PubMed ID: 20502183
[TBL] [Abstract][Full Text] [Related]
26. T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma.
Marks JA; Switchenko JM; Martini DJ; Tarabadkar ES; Khan MK; Lechowicz MJ; Allen PB
JAMA Dermatol; 2021 Aug; 157(8):954-962. PubMed ID: 34190977
[TBL] [Abstract][Full Text] [Related]
27. Multidrug resistance related proteins in primary cutaneous lymphomas.
van Haselen CW; Flens MJ; Scheper RJ; van der Valk P; Scheffer GL; Toonstra J; van Vloten WA
Adv Exp Med Biol; 1999; 457():119-31. PubMed ID: 10500787
[TBL] [Abstract][Full Text] [Related]
28. The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma.
Abraham RM; Zhang Q; Odum N; Wasik MA
Cancer Biol Ther; 2011 Dec; 12(12):1019-22. PubMed ID: 22236880
[TBL] [Abstract][Full Text] [Related]
29. Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures.
Herrera A; Cheng A; Mimitou EP; Seffens A; George D; Bar-Natan M; Heguy A; Ruggles KV; Scher JU; Hymes K; Latkowski JA; Ødum N; Kadin ME; Ouyang Z; Geskin LJ; Smibert P; Buus TB; Koralov SB
Blood; 2021 Oct; 138(16):1456-1464. PubMed ID: 34232982
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous Lymphocyte Antigen Is a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma.
Peru S; Prochazkova-Carlotti M; Cherrier F; Velazquez J; Richard E; Idrissi Y; Cappellen D; Azzi-Martin L; Pham-Ledard A; Beylot-Barry M; Merlio JP; Poglio S
J Invest Dermatol; 2022 Dec; 142(12):3243-3252.e10. PubMed ID: 35850209
[TBL] [Abstract][Full Text] [Related]
31. New insights into the applicability of T-cell receptor gamma gene rearrangement analysis in cutaneous T-cell lymphoma.
Li N; Bhawan J
J Cutan Pathol; 2001 Sep; 28(8):412-8. PubMed ID: 11493379
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma.
Delfau-Larue MH; Laroche L; Wechsler J; Lepage E; Lahet C; Asso-Bonnet M; Bagot M; Farcet JP
Blood; 2000 Nov; 96(9):2987-92. PubMed ID: 11049975
[TBL] [Abstract][Full Text] [Related]
33. T cells in the skin: Lymphoma and inflammatory skin disease.
Roediger B; Schlapbach C
J Allergy Clin Immunol; 2022 Apr; 149(4):1172-1184. PubMed ID: 35247433
[TBL] [Abstract][Full Text] [Related]
34. Increased angiogenesis in cutaneous T-cell lymphomas.
Mazur G; Woźniak Z; Wróbel T; Maj J; Kuliczkowski K
Pathol Oncol Res; 2004; 10(1):34-6. PubMed ID: 15029259
[TBL] [Abstract][Full Text] [Related]
35. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
Nevala H; Karenko L; Vakeva L; Ranki A
Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
[TBL] [Abstract][Full Text] [Related]
36. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
[TBL] [Abstract][Full Text] [Related]
37. Analyses of T-cell receptor beta-chain genes by Southern blotting in known and suspected cutaneous T-cell lymphoma. A study of 67 samples from 32 patients.
Wolff-Sneedorff A; Ralfkiaer E; Thomsen K; Vejlsgaard GL
Clin Exp Dermatol; 1995 Mar; 20(2):115-22. PubMed ID: 8565244
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
[TBL] [Abstract][Full Text] [Related]
39. Mast Cells Are Abundant in Primary Cutaneous T-Cell Lymphomas: Results from a Computer-Aided Quantitative Immunohistological Study.
Eder J; Rogojanu R; Jerney W; Erhart F; Dohnal A; Kitzwögerer M; Steiner G; Moser J; Trautinger F
PLoS One; 2016; 11(11):e0163661. PubMed ID: 27893746
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case Series.
Tang H; Matsumoto N; Foss F; Xu M; Ahmed A
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e405-e410. PubMed ID: 37659965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
